Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2026 Aug 19.
Published in final edited form as: Osteoarthritis Cartilage. 2026 Jun 17;34(10):1461–1470. doi: 10.1016/j.joca.2026.06.001

Multimodal Characterization of Articular Cartilage Degeneration in the Humeral Head Using Raman Spectroscopy, Biomechanics, and Imaging

Mason J Garcia 1,2, Dev R Mehrotra 5, Jake Giering 5, Erik E Ersland 2, Alberto Lalli 3,4, Giovanni Intermesoli 3,4, Shubham Laiwala 1, Olaia Rackauskas 1, Mario Keko 1, Prateek Misra 1, Brian D Snyder 1,2, Joseph P DeAngelis 1,6, Umile Giuseppe Longo 3,4,*, Michael B Albro 2,5,*, Arun J Ramappa 1,6,*, Ara Nazarian 1,2,5,7,*
PMCID: PMC13482738  NIHMSID: NIHMS2188491  PMID: 42309221

Abstract

Objective:

This study evaluated articular cartilage degeneration in the humeral head using a multimodal approach integrating Raman spectroscopy, mechanical testing, biochemical analysis, and micro-computed tomography (μCT). The goal was to identify sensitive biomarkers of early matrix-level degeneration that precede overt radiographic changes in glenohumeral osteoarthritis (OA).

Methods:

Eleven humeral heads were collected from cadaveric shoulders and stratified by the presence of a focal chondral defect and rotator cuff (RC) tear status, yielding four specimens without visual cartilage degeneration (controls) and seven samples (3 RC + OA, 4 OA Only) with visual defects. Raman spectroscopy was used to non-destructively quantify the contents of cartilage glycosaminoglycan (GAG), collagen (COL), and water (H2O). Tissue stiffness was assessed via indentation mechanical testing, and biochemical composition was assessed via DMMB (GAG) and OHP (COL) assays and gravimetric H2O content. μCT imaging quantified trabecular bone architecture.

Results:

Cartilage from degenerated regions exhibited decreased mechanical stiffness with a corresponding reduction in GAG and an increase in tissue hydration. Raman-derived GAGscore accounted for 68% of the variation in indentation modulus and outperformed conventional Outerbridge grading in identifying tissue with compromised mechanical function. μCT revealed thinning of subchondral trabeculae in areas adjacent to cartilage degeneration.

Conclusion:

Cartilage degeneration in the glenohumeral joint is characterized by extracellular matrix (ECM) loss, increased hydration, compromised mechanical function, and alterations to the trabecular structure. Raman spectroscopy enabled the production of non-destructive spatial maps of tissue ECM composition, highlighting the progressive OA-associated changes in specimens with and without focal defects.

Keywords: glenohumeral osteoarthritis, articular cartilage, Raman spectroscopy, Cartilage biomechanics, humeral head, rotator cuff tear, extracellular matrix degeneration

Introduction

Glenohumeral osteoarthritis (OA) leads to significant pain, discomfort, and disability. It has been reported that radiographical findings of glenohumeral OA are as high as 16–20% in the middle-aged and older adult populations1. Among patients with non-traumatic shoulder pain, glenohumeral OA is the second most common cause of shoulder pain, behind rotator cuff tears2. Furthermore, Studies have reported that 7–26% of patients with RC tears also present with concurrent OA3, 4. However, the exact pathogenesis of this disease remains largely unknown, with risk factors including obesity, sedentary lifestyle, increasing age, genetics, diet, previous joint injury, and abnormal joint loading conditions5. With an increasingly aging population, the impact of and potential treatment courses for OA have become increasingly significant, particularly with respect to the progressive deterioration of cartilage and bone. The degenerative OA changes in the hip and knee are well documented, as a greater proportion of patients experience hip and knee OA than shoulder OA6–8. However, the shoulder is the third most common large joint to be affected by OA9. Despite this, there is a lack of understanding and characterization of glenohumeral OA, with only a few studies evaluating degenerative changes within the join10–12.

Compositionally, the extracellular matrix (ECM) of the articular cartilage is largely comprised of a collagen (COL) network, which supports its structure and tensile properties, and a negatively charged glycosaminoglycan (GAG) matrix, which provides compressive strength and retains interstitial water (H2O)13, 14. These ECM constituents give rise to the capability of articular cartilage in resisting compressive and shear loads, while maintaining low-friction joint locomotion15, 16. Degeneration of these constituents can manifest as chondral lesions, which, if left untreated, progress until bone-on-bone contact occurs. Studies have shown that glenohumeral OA results in a loss of cartilage thicknes11 and increased histological scorin10, 12, indicating structural and compositional changes. However, these studies were limited to end-stage glenohumeral OA and did not examine the specific mechanical or compositional changes in the regions where defects are present. Thus, it remains unclear whether osteoarthritis progression in the non-weight-bearing glenohumeral joint exhibits patterns of cartilage degeneration and phenotypic change comparable to those observed in weight-bearing joints such as the hip and knee.

Glenohumeral OA often progresses insidiously, likely with early changes in cartilage composition preceding macroscopic defects or joint space narrowing. In this study, tissue was harvested from cadaveric shoulders exhibiting focal chondral defects and similar-matched controls. This study focuses on the degenerative changes experienced by cartilage and trabecular bone, which may be relevant for early intervention and detection of OA, prior to the end-stage of the disease, where clinical intervention typically involves joint replacement. The objective is to evaluate compositional and mechanical changes associated with cartilage degeneration in cadaveric humeral head specimens exhibiting focal chondral defects, both with and without RC tears. Cartilage composition will be assessed using Raman spectroscopy, a non-invasive technique that utilizes inelastic light scattering to reflect tissue molecular bond vibrational modes, generating an “optical fingerprint” of tissue composition17. An intra-articular-compatible Raman probe will be used to enable non-destructive assessment of cartilage18–20. Through a multivariate spectral decomposition analysis, ECM-specific optical biomarkers reflecting cartilage composition are extracted18–20. These Raman-based measurements will be complemented by biochemical analysis, mechanical testing, and micro-computed tomography (μCT) to comprehensively assess changes in cartilage composition and mechanical integrity, as well as alterations in subchondral bone structure associated with glenohumeral OA. First, hypothesize that degenerative changes in the humeral head due to OA result in measurable alterations in extracellular matrix composition and mechanical stiffness as well as changes to the trabecular bone architecture. Second, we hypothesize that OA + RC will have differing regions of degeneration but similar changes to composition due to the shifting of the humeral head as a result of RC tear.

Methods

Tissue Samples

The humeral heads from eleven fresh frozen disarticulated cadaveric shoulders (6 Male/5 Female) with a mean age of 61 ± 4 years old were used in this study (Medcure, Providence, RI, USA). The specimens were then divided into two groups based on visual macroanalysis of the humeral head cartilage. All specimens were obtained in this age range to ensure both groups were of similar age, and we were not comparing young, healthy samples to older degenerated samples. Specimens with no visual signs of cartilage degeneration were designated to the intact control group (N = 4; mean age 62 ± 3) and specimens with visual focal defects to the cartilage were designated to the defect group (N = 7; mean age 60 ± 4). Sites with full cartilage erosion (exposed subchondral bone) were not subjected to analysis. Of the humeral heads that had evidence of degeneration, 3 came from specimens where there was a concurrent rotator cuff tear identified upon dissection by inspection of the supraspinatus tendon. The humeral heads were then sectioned using a rectangular grid pattern to create square osteochondral blocks using a fine-tooth handsaw (N = 7–10 blocks/humeral head)19. Overall, this yielded 90 osteochondral samples across all donors for subsequent testing. Specimens that had no signs of macro-degeneration were assigned to the intact group (n = 66 osteochondral specimens) and those with visual focal defects were assigned to the defect group (n = 24 osteochondral specimens). Tissue samples were subjected to Raman spectroscopy, mechanical indentation, biochemical analysis (GAG, COL, H2O content), μCT imaging, histology, and Outerbridge visual grading. All specimens were kept hydrated in 1× PBS and stored at −20 °C.

Raman Spectroscopy

The Raman instrumentation is comprised of a custom Raman probe, with a threaded, hollow needle tip possessing a distal mounted ∅2mm diameter sapphire ball lens (InPhotonics, Norwood, MA, USA), coupled to an NIR diode laser (ex = 785 nm; 125 mW output; IPS) and a spectrometer (Eagle Raman-S, Ibsen Photonics, Farum, Denmark) equipped with a near infrared (NIR) optimized charge coupled device (Ivac, Andor, Belfast, Northern Ireland) Andor)19. The distal end of this needle probe contains a ∅2mm sapphire ball lens, with the focal distance being close to zero requiring direct contact with the cartilage surface for sufficient spectral acquisition. For Raman spectral acquisitions, the probe tip was positioned perpendicular to the articular surface of each osteochondral explant (N = 90; N = 66 Intact, N = 24 Defect), and spectra were acquired using a 30s integration time. Following subtraction of the probe background, a 3rd order polynomial baseline correction and subsequent area-under-curve normalization were applied to the 800–1800 cm−1 spectral “fingerprint” region. The resulting “fingerprint” spectrum was decomposed using the following multivariate regression model20:

Cartilagespectra=GAGscore*GAGref+COLscore*COLref+H2Oscore*H2Oref+Bonescore*Boneref

The derived regression coefficients (GAGscore, COLscore, H2Oscore, BoneScore) reflect the relative contribution of each individual constituent to the overall composite spectrum, thereby providing a non-destructive assessment of individual osteochondral explant composition (Figure 1). GAGREF, CollagenREF, H2OREF, and BoneREF are reference spectra measured from purified chemicals of each constituent (Figure 1C): GAGREF= chondroitin sulfate [bovine cartilage; C6737 Sigma]; CollagenREF= type-II collagen [chicken sternal cartilage; C9301 Sigma]; H2OREF= PBS; BoneREF= Mature bovine subchondral bone.

Figure 1.

Figure 1.

Stacked area plot showing the cumulative contribution of GAG, COL, H2O, and Bone of the Raman fingerprint region for an intact sample (A), and a sample with a focal defect (B), where the bar graph depicts the relative contribution of each component obtained from the spectra. (C) shows the reference spectra for each component used for the spectral decomposition into the ECM constituents.

Mechanical Testing

Each osteochondral explant (N = 90) was subject to indentation testing at the center of the cartilage layer using a custom mechanical testing machine (CellScale Biomaterials, Waterloo, ON, Canada). A ∅2mm diameter spherical indenter was used to apply a 100 μm tissue displacement at a loading rate of 5 μm/s to obtain the cartilage force-displacement response. The compressive modulus was then obtained assuming Hertzian contact theory for the loading curve21.

Outerbridge Scoring

A visual assessment of the cartilage breakdown was performed for all specimens with a visual defect (N = 24) and a random subset of visually intact specimens (N = 10) to assess the relationship between clinical assessments of cartilage and mechanical function. A single experienced orthopaedic shoulder surgeon graded the specimens according to the Outerbridge classification system22. The Outerbridge classification was chosen because it represents the current convention for assessing cartilage health during arthroscopic procedures and has previously been used to assess shoulder joint articular cartilage23.

Biochemical Analysis

A central ∅4mm chondral sub-punch was collected from the center of each osteochondral explant (N = 76; N = 56 Intact, N = 19 Defect), co-localized with the region subjected to mechanical and Raman assessments. Upon separation of the cartilage from the bone, the wet weight of the cartilage was recorded. Following lyophilization, the tissue dry weight was measured, providing the gravimetric water content. Subsequently, the tissue was digested with proteinase K and analyzed for GAG and collagen content using 1,9-dimethylmethylene blue (DMMB) and orthohydroxyproline (OHP) assays, respectively.

Histological Evaluation

A random subset of degenerated (N = 3) and intact (N = 3) osteochondral specimens was fixed in formalin, embedded in paraffin, sectioned, and stained with safranin-O/fast green to assess the presence of GAG. Slides were imaged with a 20× objective on a standard bright-field microscope to provide representative images of intact and degenerated tissue (Figure 3A and 3 B).

Figure 3.

Figure 3.

A) Comparison of the elastic modulus between intact and defect samples. B.) Relationship between Outerbridge classification and compressive modulus. Correlation between Outerbridge classification and compressive modulus was compared using spearman’s rank. * Represents p < 0.05. Histological images of C.) three intact and D.) three osteochondral specimens with a defect. GAG is stained in red. The area of the focal defect is denoted by a red star, where testing was performed. Intact samples show a uniform deep layer of GAG with loss of staining in the superficial zone. Specimens with a defect show a loss of GAG at the defect site.

Micro-computed Tomography

Osteochondral specimens were scanned (N = 23 degenerated, N = 19 intact controls from defect-free humeral heads) (μCT40, SCANCO Medical, Brütisellen, Switzerland) under the following conditions: The x-ray tube was operated at 70 kVp, an intensity of 114 mA and an integration time of 300 ms. This resulted in an isotropic voxel size of 15μm. The bone density and micro-architectural indices (Bone Mineral Density (BMD, mgHA/cm3 ), Bone Volume Fraction (BV/TV, mm3/mm3), Trabecular Thickness (Tb.Th, mm), and Connectivity Density (Conn.D, 1/mm3) were calculated along the central 20 slices of each specimen, where a 2mm volume of interest was manually drawn directly adjacent to the cartilage layer, allowing for the evaluation of changes in trabecular bone.

Statistical Analysis

All data is presented as median (interquartile range). We used the proc mixed from the SAS software, version 9.4 for the Windows System to implement a mixed model for testing the differences in the selected “compositional/mechanical/ μCT variables” (i.e., Modulus, GAG, COL, H2O, BMD, BV/TV, Conn.D, Tb.Th) by the presence of “damage” (i.e., Intact or Defect; RCT or RCT + OA) in the “cartilage sample” (i.e., each specimen). We used a linear mixed-effects model with random intercepts to address multiple measurements from the same subject. Spearman’s rank test was used to determine the correlation between Outerbridge grade and compressive modulus. A nonlinear (2nd order polynomial) regression was performed to determine the extent to which variation in the Raman GAGscore accounted for the variation in compressive modulus as assessed by the coefficient of determination (adjusted R2). Two-tailed p-values < 0.05 were considered significant. The specimens obtained were based on what was available, and no a priori sample size or power calculations was performed.

Results

Spatial Maps of Humeral Head Degeneration from Raman Spectroscopy

Spatial maps of the cartilage mechanical function and Raman-derived biomarkers for specimens with increasing levels of degeneration are shown in Figure 2 to illustrate the compositional and mechanical changes that occur as cartilage degenerates. Shown are two intact controls, one specimen with a small defect (< 0.5 cm2) and one specimen with a larger defect (> 1.5 cm2), to highlight the changes in the degenerated regions as the focal defect increases in size. Here we see the progression from an intact control with seemingly uniform mechanical and compositional properties, to the complete loss of mechanics and composition when the defect comprises most of the humeral head.

Figure 2.

Figure 2.

Spatial maps of the compressive modulus and Raman-derived biomarkers from a subset of samples with increasing levels of degeneration. Specimens A and B represent two intact controls. C and D represent specimens with increasing defect sizes, where C has a defect area of 0.41 cm2, and D has a defect area of 1.58 cm2 with a complete absence of cartilage and visible subchondral bone in the center of the defect. In the inferior center region of specimen D, no data was taken because it was absent of cartilage in this location.

Cartilage Mechanical Health

Cartilage degeneration resulted in a significant decrease in mechanical function, as evidenced by a reduction in the compressive modulus. The osteochondral specimens with focal defects had a lower elastic modulus than the intact group (Table 1 & Figure 3A). Clinically, cartilage health can be assessed during arthroscopic procedures, where the degree of degeneration can be graded on the Outerbridge scale (0-IV). Therefore, we compared the relationship between Outerbridge grade and the elastic modulus to assess if the gold standard for cartilage degeneration can explain mechanical degradation. In the osteochondral specimens with defects and 10 randomly chosen visually intact specimens (Outerbridge Grade 0). No correlation (p = 0.13) between the elastic modulus and Outerbridge classification (Figure 3B) was found in this subset of specimens.

Table 1.

comparison of the mechanical, cartilage compositional, and trabecular properties between intact and defect specimen. Data is displayed as the median (Q3 – Q1) for all samples within each group. p-value is estimated from the linear mixed effects model. Biochemical assays were evaluated for a total of 77 osteochondral specimens (N = 56 Intact, N = 19 Defect), Bone microarchitecture was for evaluated for a subset of all osteochondral specimens (N = 22 intact, N = 19 defect).

Property Intact (N = 66) Defect (N = 24) p-value

Modulus (MPa) 1.52 (1.99 – 1.04) 0.59 (0.89 – 0.36) < 0.001
Raman GAG Score 0.037 (0.051 – 0.029) 0.27 (0.034 – 0.017) 0.001
Raman COL Score 0.77 (0.79 – 0.74) 0.74 (0.77 – 0.70) 0.146
Raman H2O Score 0.13 (0.16 – 0.10) 0.18 (0.21 – 0.13) 0.110
% ww GAG 2.8 (4.0 – 1.7) 2.3 (3.2 – 1.4) 0.030
% ww COL 8.2 (10.4 – 6.6) 6.9 (8.7 – 5.6) 0.073
% ww H2O 72.7 (74.0 – 69.8) 75.4 (77.8 – 71.1) 0.007
BV/TV 0.44 (0.49 – 0.39) 0.37 (0.44 – 0.28) 0.011
BMD (mg HA/mm3) 717.6 (728.2 – 708.2) 719.9 (730.2 – 712.2) 0.426
Conn.D (1/mm3) 78.0 (103.7 – 50.0) 26.4 (74.8 – 13.7) 0.137
Tb.Th (mm) 0.125 (0.132 – 0.115 0.124 (0.127 – 0.113) 0.751

Histological Assessment of Cartilage

The three intact (Figure 3C) and defective (Figure 3D) specimens were qualitatively evaluated to verify the presence/absence of GAG. In intact samples, we observe uniform cartilage thickness and GAG in the deep zone. Although one sample (Figure 3C–3) appears to have a loss of GAG, which could be attributed to early degenerative changes, where cartilage thinning has not yet occurred. Furthermore, there is a lack of GAG in the superficial layer, which may be attributed to the advanced age of these specimens, as they are likely to have undergone degeneration due to aging26. Similarly, the advanced age of these specimens may explain the absence of a GAG signal in the cartilage's superficial region. In the defect samples, there is heterogeneity in the cartilage thickness, where there is a loss of GAG signal directly under the site of cartilage thinning (Figure 3D).

Comparison of Cartilage Degeneration to Intact Controls

Regions containing focal defects exhibited significant compositional changes relative to intact controls, as measured by both Raman spectroscopy and biochemical analysis (Table 1 and Figure 4). Raman spectroscopy and biochemical analysis revealed a significant reduction in GAG levels between intact and focal-defect samples. Biochemical analysis also revealed a significant increase in tissue hydration. While the Raman-derived H2O and COL did not reach significance between the defect and controls, there was a slight decrease in COL and an increase in H2O. Raman-derived biomarkers were also found to have positive correlations to their corresponding biochemical assays (GAGscore vs GAG content, R2 = 0.54, p < 0.001; COLscore vs. COL content, R2 = 0.19, p = 0.016; H2Oscore vs H2O content, R2 =0.19, p < 0.001).

Figure 4.

Figure 4.

Compositional changes measured via biochemical analysis and Raman spectroscopy, where all specimens without visual degeneration were denoted as the intact group (N=66), and all specimens with visual degeneration were denoted as the defect group(N=24). A.) GAG content, B.) COL content, C.) H2O content, D.) GAGscore E.) COLscore, and F.) H2Oscore. All data is shown as median with the interquartile range. ‘*’ represents p < 0.05.

Correlation between Raman-derived biomarkers and mechanical function

Overall, intact cartilage had a higher compressive modulus than regions with focal lesions. As a result of degeneration, there was a loss of GAG within the cartilage, which was seen in both the GAGscore and GAG content. A 2nd-order polynomial fit using the Raman-derived GAGscore captured 68% of the variability in the compressive modulus of the osteochondral specimens (Figure 5), indicating that stiffer tissue was associated with higher GAGscore (adjusted R2 = 0.68, p < 0.001).

Figure 5.

Figure 5.

Relationship between Raman-derived GAGscore and measured compressive moduli for all specimens, with the line of best fit shown.

Bone microarchitecture

μCT imaging revealed changes to the underlying trabecular structure of the specimens with a defect (Table 1 and Figure 6). There was a significant reduction in BV/TV (p = 0.011). Yet, there were no statistically significant differences in BMD, Conn.D, or Tb.Th.

Figure 6.

Figure 6.

Changes in trabecular bone microstructure, showing the μ CT 3-D reconstruction of the osteochondral block from the central 200 μm that was analyzed from A.) a humeral head without a focal defect and B.) a specimen with a focal defect. C.) depicts the ratio of bone volume/total volume (BV/TV), D.) depicts the bone mineral density (BMD) of the bone obtained from a 2mm region of interest below the cartilage layer. All data is shown as median with the interquartile range. ‘*’ represents p < 0.05.

Comparison of Degeneration with RC Injury

To assess if RC injury results in differences in the compositional and mechanical changes of cartilage, we compared the Raman-derived biomarkers and compressive modulus of the osteochondral samples with macroscopic damage (focal defects) from humeral heads with RC tears versus those without RC tears (Figure 7). This resulted in n = 10 osteochondral specimens in the RC tear + OA groups and n = 14 osteochondral specimens in the OA only group. Overall, no statistically significant differences in the compositional or mechanical properties between specimens with RCT + OA versus OA (Table 2 and Figures 7A–D) were seen. No statistically significant differences were found between the RCT + OA group compared to the OA only group for BV/TV, BMD, Conn.D, or Tb.Th.

Figure 7.

Figure 7.

Comparison of Raman-derived biomarkers and μCT measurements between specimens that had rotator cuff tears (RCT) + OA (N = 10) versus those with only OA (N=14) in specimens containing focal defects. Assessing A.) GAGscore, B.) COLscore, C.) H2Oscore, D) compressive modulus, E.) BV/TV, and F) BMD. G.) OA only and H.) OA + RCT, show the location of cartilage degeneration on an outline of a humeral head. Anatomical labels indicate the superior (S) – inferior (I) axis and the anterior (A) – posterior (P). Colors on each head represent the location obtained from the different specimens, where three specimens had RC tears + OA and four specimens had only OA. Each color represents the location of degeneration for one specimen. All data is shown as median with the interquartile range. ** It should be noted that one specimen had two distinct regions of degeneration, which is why blue is used twice in B.

Table 2.

Sub-group analysis comparing the mechanical, cartilage compositional, and trabecular properties between specimens with RCT + OA or OA only. Data are displayed as the median (Q3–Q1) for all samples within each group. p-value is estimated from the linear mixed effects model. The RCT + OA group contained 10 osteochondral samples from 3 humeral heads, and the OA only group contained 14 osteochondral samples from 4 humeral heads. + Bone microarchitecture was evaluated for a subset of all osteochondral specimens (N = 9 RCT + OA, N = 10 OA only).

Property RCT + OA OA Only p-value

Modulus (MPa) 0.45 (0.91 – 0.25) 0.63 (0.92 – 0.51) 0.863
Raman GAG Score 0.021 (0.034 – 0.014) 0.032 (0.035 −0.022) 0.820
Raman COL Score 0.73 (0.77 – 0.66) 0.74 (0.76 – 0.70) 0.331
Raman H2O Score 0.19 (0.21 – 0.10) 0.16 (0.21 – 0.13) 0.475
BV/TV 0.35 (0.51 – 0.29) 0.37 (0.40 – 0.21) 0.286
BMD (mg HA/mm3) 719.9 (733.5 – 705.2) 717.9 (730.2 – 712.1) 0.364
Conn.D (1/mm3) 26.35 (105.8 – 20.5) 25.38 (52.4 – 13.1) 0.265
Tb.Th (mm) 0.121 (0.128 – 0.117) 0.124 (0.128 – 0.113) 0.997

Cartilage degeneration was generally seen in the central portion of the humeral head (Figure 7), consistent with previous studies evaluating end-stage OA10, 11. However, different phenotypes of OA may exist due to concurrent pathology, such as RC arthropathy. Three of the humeral heads with cartilage degeneration also had RC tears; therefore, we plotted the location of degeneration to qualitatively identify changes in the wear pattern. Cartilage degeneration was located centrally when there was no RC tear (Figure 7G); however, the specimens with a RC tear (n = 3) exhibited an inferior shift in the degeneration sites (Figure 7H).

Discussion

Our study directly evaluates the degenerative alterations in glenohumeral OA. We observed a significant reduction in glycosaminoglycan (GAG) content, a critical component of the extracellular matrix (ECM), as well as elevated water content (H2O), all measured via biochemical and Raman-derived scores. These findings align with established OA models where early cartilage degeneration is associated with GAG depletion, ECM swelling (increased hydration), and eventual disruption of the collagen network7. This degradation cascade reduces stiffness and increases permeability, impairing the tissue’s capacity to resist compressive forces27.

Numerous studies have assessed the thickness of humeral head articular cartilage28–31, but these are largely limited to non-degenerated samples, with only one study examining the native mechanical properties31. Although cartilage is generally thickest centrally and thinnest peripherally28, compressive properties do not appear to differ regionally31. While cartilage thinning is a hallmark of OA, it offers limited insight into underlying compositional and mechanical changes. Raman spectroscopy enables non-destructive evaluation of tissue composition and distinguishes between intact and degenerated cartilage samples. We found that compositional degeneration, as measured by Raman spectroscopy, decreases the tissue’s resistance to compression, with the Raman-derived GAGscore accounting for 68% of the variation in the compressive modulus. GAGscore offers a useful metric to evaluate cartilage mechanical function and can potentially distinguish regions where cartilage visually appears healthy but is functionally deficient. Thus, Raman spectroscopy provides a sensitive, non-destructive approach to detect early, matrix-level degeneration that precedes visible thinning, offering valuable insight into cartilage pathology and a potential tool for early OA detection in the shoulder.

While our study demonstrates that glenohumeral osteoarthritis (OA) involves cartilage degeneration leading to compositional loss and reduced mechanical function, it is important to recognize OA as a whole-joint disease that also affects subchondral bone architecture32. Prior studies have reported central thickening of the subchondral bone plate in humeral heads, indicative of sclerosis10, 11, though these analyses were limited to specimens from patients with end-stage OA. Using μCT imaging, we evaluated trabecular bone beneath focal cartilage defects and found structural deterioration, including a significant reduction in BV/TV compared to intact controls. These findings align with previous work, showing trabecular deterioration is an early feature of OA33. The absence of increased BMD, a hallmark of late-stage OA-associated sclerosis33, suggests that the cadaveric samples may reflect early-stage OA. Our results reinforce the notion that cartilage degeneration in glenohumeral OA occurs alongside early, yet measurable, alterations in subchondral bone structure, highlighting the joint-wide nature of the disease.

This study demonstrates that cartilage degeneration in the glenohumeral joint mirrors the patterns observed in weight-bearing joints such as the hip and knee. In these joints, OA is characterized by ECM degradation, including a loss of GAG, COL, and increased tissue hydration34–36. While abnormal mechanical loading has been implicated in initiating degeneration through structural and functional alterations in cartilage and bone37, OA is now recognized as a multifactorial disease, with inflammation38 and metabolic dysregulation51 also contributing significantly. Though the shoulder is not subjected to the same loading as weight-bearing joints, it is not immune to these biological mechanisms. Disruption in the RC force balance, particularly due to RC tears, can result in eccentric loading of the glenohumeral joint39, 40, increasing cartilage stress and potentially triggering damage. This altered biomechanics, coupled with an inflammatory response, may explain why shoulder OA shares phenotypic similarities with weight-bearing joint degeneration. This study found that cartilage degeneration occurs predominantly in the central region of the humeral head, consistent with previous studies evaluating end-stage shoulder O10–12. RC tears alter the mechanical environment of the glenohumeral joint, and as tears progress, the force couples acting across the glenohumeral joint become unbalanced, which results in superior migration of the humeral head41–43. As a result of the altered mechanical environment, degenerative changes to the joint may occur, often referred to as RC arthropathy44–46. The superior migration of the humeral head leads to abnormal wear conditions of the humeral head, as the inferior region of the humeral head meets the glenoid. Although our sample size of specimens with RC tears and cartilage degeneration is small, this may explain why we observe an apparent inferior shift in the location of degeneration in joints with RC tears.

Understanding osteoarthritis (OA) development in the glenohumeral joint is crucial, as age, overuse, and co-existing injuries, such as rotator cuff (RC) tears, can damage the humeral head articular cartilage47. Even after successful RC repair, OA can develop in 12–29% of patients within 10 years47, despite evidence that RC repair helps restore native joint loading48. This suggests biomechanical alterations may initiate cartilage degeneration before macroscopic signs appear. Our study demonstrates that Raman spectroscopy can non-destructively assess cartilage composition, building on prior findings linking composition to functio19, 20, 49. In the future, Raman spectroscopy may offer the potential for in-vivo measurements of cartilage health50, which could help identify patients at risk of developing OA after RC repair. Notably, Raman-derived assessments have the ability to assess the compositional and mechanical deficits in cartilage that appear visually intact19, which Outerbridge grading, the current clinical gold standard, failed to detect.

This study should be interpreted in light of its limitations. The sample size was limited, especially in subgroups with cartilage degeneration and concurrent RC tears, necessitating pooling all degenerated samples. This reflects the challenge of acquiring such specimens. Furthermore, within our control group, it is likely that they do not represent true “healthy” levels of ECM composition and mechanical function, which may be lost due to aging26, but precede macroscopic damage. Another explanation as to why the GAG may seem lower compared to previous studies in the knee19, 20, is that the shoulder is non-weight bearing and sees smaller compressive forces compared to the knee, making it plausible that GH cartilage is softer and naturally has less GAG. While cadaveric samples offer important insights into tissue composition and mechanics, they may not fully represent in vivo behavior or disease progression, as assessments were limited to static measurements. The absence of end-stage OA samples also restricted comparisons and may have prevented the observation of advanced changes, such as subchondral sclerosis, or the ability to definitively say that these samples represent early OA. Nevertheless, despite these constraints, the study provides important new insights into previously uncharacterized early degenerative changes in cartilage and bone within the glenohumeral joint.

This study presents the first comprehensive multimodal analysis of articular cartilage degeneration in the humeral head using Raman spectroscopy, mechanical testing, biochemical assays, and μCT imaging to characterize early osteoarthritic changes. Subchondral bone thinning without sclerosis indicates early glenohumeral OA, aligning with changes seen in weight-bearing joints. We found that focal degeneration is associated with consistent extracellular matrix changes and reduced stiffness. Raman-derived biomarkers were highly correlated to cartilage mechanical properties and outperformed Outerbridge grading in detecting early degeneration.

Funding Sources

The Joe Fallon Research Fund (AJR, AN), the Dr. Louis Meeks BIDMC Sports Medicine Trainee Research Fund (AJR, AN), and National Institutes of Health (R01AR081393) (MBA) provided the funding for this study.

Footnotes

Conflict of Interest

The authors have no conflicts to report.

Use of Generative AI

No large language models or AI-based tools were utilized to prepare this manuscript.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Ibounig T, Simons T, Launonen A, Paavola M. Glenohumeral osteoarthritis: an overview of etiology and diagnostics. Scand J Surg 2021; 110: 441–451. [DOI] [PubMed] [Google Scholar]
  • 2.Schoenfeldt TL, Trenhaile S, Olson R. Glenohumeral osteoarthritis: frequency of underlying diagnoses and the role of arm dominance-a retrospective analysis in a community-based musculoskeletal practice. Rheumatol Int 2018; 38: 1023–1029. [DOI] [PubMed] [Google Scholar]
  • 3.Gartsman GM, Taverna E. The incidence of glenohumeral joint abnormalities associated with full-thickness, reparable rotator cuff tears. Arthroscopy 1997; 13: 450–455. [DOI] [PubMed] [Google Scholar]
  • 4.Miller C, Savoie FH. Glenohumeral abnormalities associated with full-thickness tears of the rotator cuff. Orthop Rev 1994; 23: 159–162. [PubMed] [Google Scholar]
  • 5.Crane C, Wagner C, Wong S, Hall B, Hull J, Irwin K, et al. Glenohumeral Osteoarthritis: A Biological Advantage or a Missed Diagnosis? J Clin Med 2024; 13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Katz JN, Arant KR, Loeser RF. Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review. Jama 2021; 325: 568–578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Goldring SR, Goldring MB. Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk. Nat Rev Rheumatol 2016; 12: 632–644. [DOI] [PubMed] [Google Scholar]
  • 8.Long H, Liu Q, Yin H, Wang K, Diao N, Zhang Y, et al. Prevalence Trends of Site-Specific Osteoarthritis From 1990 to 2019: Findings From the Global Burden of Disease Study 2019. Arthritis Rheumatol 2022; 74: 1172–1183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med 2010; 26: 355–369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Matson AP, Kunkel Z, Bernal-Crespo VA, Chainani A, Chainani M, Finley SJ, et al. The histopathology of the humeral head in glenohumeral osteoarthritis. Osteoarthr Cartil Open 2021; 3: 100147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Pawson DJ, Glanzmann M, Luechinger R, Müller R, Stok KS. Quantitative morphometric patterns in cartilage and bone from the humeral heads of end-stage osteoarthritis patients. Osteoarthritis Cartilage 2015; 23: 1377–1387. [DOI] [PubMed] [Google Scholar]
  • 12.Toegel S, Martelanz L, Alphonsus J, Hirtler L, Gruebl-Barabas R, Cezanne M, et al. The degenerated glenohumeral joint. Bone Joint Res 2024; 13: 596–610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Maroudas A, Venn M. Chemical composition and swelling of normal and osteoarthrotic femoral head cartilage. II. Swelling. Ann Rheum Dis 1977; 36: 399–406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Camarero-Espinosa S, Rothen-Rutishauser B, Foster EJ, Weder C. Articular cartilage: from formation to tissue engineering. Biomater Sci 2016; 4: 734–767. [DOI] [PubMed] [Google Scholar]
  • 15.Krishnan R, Kopacz M, Ateshian GA. Experimental verification of the role of interstitial fluid pressurization in cartilage lubrication. J Orthop Res 2004; 22: 565–570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ateshian GA. The role of interstitial fluid pressurization in articular cartilage lubrication. J Biomech 2009; 42: 1163–1176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Raman CV, Krishnan KS. A New Type of Secondary Radiation. Nature 1928; 121: 501–502. [Google Scholar]
  • 18.Jensen M, Horgan CC, Vercauteren T, Albro MB, Bergholt MS. Multiplexed polarized hypodermic Raman needle probe for biostructural analysis of articular cartilage. Opt Lett 2020; 45: 2890–2893. [DOI] [PubMed] [Google Scholar]
  • 19.Kazemi M, Yu C, Mehrotra DR, Ersland EE, Zbyn S, Korna F, et al. Raman spectroscopic probe provides optical biomarkers of cartilage composition predictive of tissue function. Osteoarthritis Cartilage 2025; 33: 461–472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kroupa KR, Wu MI, Zhang J, Jensen M, Wong W, Engiles JB, et al. Raman needle arthroscopy for in vivo molecular assessment of cartilage. J Orthop Res 2022; 40: 1338–1348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Fischer-Cripps AC. The Hertzian contact surface. Journal of Materials Science 1999; 34: 129–137. [Google Scholar]
  • 22.Outerbridge RE. The etiology of chondromalacia patellae. J Bone Joint Surg Br 1961; 43-b: 752–757. [DOI] [PubMed] [Google Scholar]
  • 23.Slattery C, Kweon CY. Classifications in Brief: Outerbridge Classification of Chondral Lesions. Clin Orthop Relat Res 2018; 476: 2101–2104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986; 883: 173–177. [DOI] [PubMed] [Google Scholar]
  • 25.Stegemann H, Stalder K. Determination of hydroxyproline. Clin Chim Acta 1967; 18: 267–273. [DOI] [PubMed] [Google Scholar]
  • 26.Keenan KE, Besier TF, Pauly JM, Han E, Rosenberg J, Smith RL, et al. Prediction of glycosaminoglycan content in human cartilage by age, T1ρ and T2 MRI. Osteoarthritis Cartilage 2011; 19: 171–179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Katta J, Stapleton T, Ingham E, Jin ZM, Fisher J. The effect of glycosaminoglycan depletion on the friction and deformation of articular cartilage. Proc Inst Mech Eng H 2008; 222: 1–11. [DOI] [PubMed] [Google Scholar]
  • 28.Fox JA, Cole BJ, Romeo AA, Meininger AK, Williams JM, Glenn RE Jr, et al. Articular cartilage thickness of the humeral head: an anatomic study. Orthopedics 2008; 31: 216. [DOI] [PubMed] [Google Scholar]
  • 29.Hodler J, Loredo RA, Longo C, Trudell D, Yu JS, Resnick D. Assessment of articular cartilage thickness of the humeral head: MR-anatomic correlation in cadavers. AJR Am J Roentgenol 1995; 165: 615–620. [DOI] [PubMed] [Google Scholar]
  • 30.Yeh LR, Kwak S, Kim YS, Chou DS, Muhle C, Skaf A, et al. Evaluation of articular cartilage thickness of the humeral head and the glenoid fossa by MR arthrography: anatomic correlation in cadavers. Skeletal Radiol 1998; 27: 500–504. [DOI] [PubMed] [Google Scholar]
  • 31.Loy BN, Zimel M, Gowda AL, Tooley TR, Maerz T, Bicos J, et al. A Biomechanical and Structural Comparison of Articular Cartilage and Subchondral Bone of the Glenoid and Humeral Head. Orthop J Sports Med 2018; 6: 2325967118785854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Poole AR. Osteoarthritis as a whole joint disease. Hss j 2012; 8: 4–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Li G, Yin J, Gao J, Cheng TS, Pavlos NJ, Zhang C, et al. Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes. Arthritis Res Ther 2013; 15: 223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Cooke ME, Lawless BM, Jones SW, Grover LM. Matrix degradation in osteoarthritis primes the superficial region of cartilage for mechanical damage. Acta Biomater 2018; 78: 320–328. [DOI] [PubMed] [Google Scholar]
  • 35.Kleemann RU, Krocker D, Cedraro A, Tuischer J, Duda GN. Altered cartilage mechanics and histology in knee osteoarthritis: relation to clinical assessment (ICRS Grade). Osteoarthritis Cartilage 2005; 13: 958–963. [DOI] [PubMed] [Google Scholar]
  • 36.de Roy L, Teixeira GQ, Schwer J, Sukopp M, Faschingbauer M, Ignatius A, et al. Structure-function of cartilage in osteoarthritis: An ex-vivo correlation analysis between its structural, viscoelastic and frictional properties. Acta Biomater 2024; 190: 293–302. [DOI] [PubMed] [Google Scholar]
  • 37.Guilak F Biomechanical factors in osteoarthritis. Best Pract Res Clin Rheumatol 2011; 25: 815–823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Berenbaum F Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage 2013; 21: 16–21. [DOI] [PubMed] [Google Scholar]
  • 39.Pataky J, Seelam V, Engle L, Khandare S, Armstrong AD, Vidt ME. Glenohumeral joint loading is impacted by rotator cuff tear severity during functional task performance. Clin Biomech (Bristol) 2021; 90: 105494. [DOI] [PubMed] [Google Scholar]
  • 40.Vidt ME, Santago AC 2nd, Marsh AP, Hegedus EJ, Tuohy CJ, Poehling GG, et al. Modeling a rotator cuff tear: Individualized shoulder muscle forces influence glenohumeral joint contact force predictions. Clin Biomech (Bristol) 2018; 60: 20–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Nam D, Maak TG, Raphael BS, Kepler CK, Cross MB, Warren RF. Rotator cuff tear arthropathy: evaluation, diagnosis, and treatment: AAOS exhibit selection. J Bone Joint Surg Am 2012; 94: e34. [DOI] [PubMed] [Google Scholar]
  • 42.Siow MY, Mitchell BC, Hachadorian M, Wang W, Bastrom T, Kent WT, et al. Association Between Rotator Cuff Tears and Superior Migration of the Humeral Head: An MRI-Based Anatomic Study. Orthop J Sports Med 2021; 9: 23259671211009846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Keener JD, Wei AS, Kim HM, Steger-May K, Yamaguchi K. Proximal humeral migration in shoulders with symptomatic and asymptomatic rotator cuff tears. J Bone Joint Surg Am 2009; 91: 1405–1413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Chalmers PN, Salazar DH, Steger-May K, Chamberlain AM, Stobbs-Cucchi G, Yamaguchi K, et al. Radiographic progression of arthritic changes in shoulders with degenerative rotator cuff tears. J Shoulder Elbow Surg 2016; 25: 1749–1755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Hamada K, Fukuda H, Mikasa M, Kobayashi Y. Roentgenographic findings in massive rotator cuff tears. A long-term observation. Clin Orthop Relat Res 1990: 92–96. [PubMed] [Google Scholar]
  • 46.Zingg PO, Jost B, Sukthankar A, Buhler M, Pfirrmann CW, Gerber C. Clinical and structural outcomes of nonoperative management of massive rotator cuff tears. J Bone Joint Surg Am 2007; 89: 1928–1934. [DOI] [PubMed] [Google Scholar]
  • 47.Ruckstuhl H, de Bruin ED, Stussi E, Vanwanseele B. Post-traumatic glenohumeral cartilage lesions: a systematic review. BMC Musculoskelet Disord 2008; 9: 107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Muench LN, Berthold DP, Otto A, Dyrna F, Bell R, Obopilwe E, et al. Increased Glenohumeral Joint Loads Due to a Supraspinatus Tear Can Be Reversed With Rotator Cuff Repair: A Biomechanical Investigation. Arthroscopy 2022; 38: 1422–1432. [DOI] [PubMed] [Google Scholar]
  • 49.Mehrotra DR, Cordova CV, Wang T, Ersland EE, Zhang J, Staffa SJ, et al. Evaluation of Engineered Cartilage Composition and Function Using Raman Spectroscopy. Adv Healthc Mater 2025; 14: e00552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Ersland MB EE, Santos M, Fusco A, Mehrotra D, Giering J, Karimi M, Ahadi F, Han L-H, Lawrence JT, Schaer TP, Grinstaff MW, Bergholt M, Snyder B, Albro MB In-Vivo Raman Spectroscopy Can Longitudinally Monitor Neocartilage Maturation. Orthopedic Research Society 20252025. [Google Scholar]

RESOURCES